FindTrial
Sign In

Atorvastatin 20 mg

DRUG10 trials

Sponsors

Aegerion Pharmaceuticals, Inc., Organon and Co, Chulalongkorn University, Creighton University, Yonsei University

Conditions

Cardiothoracic SurgeryCirrhosisDecompensated Cirrhosis and AscitesDecompensated Cirrhosis of LiverDecompensated Liver CirrhosisDifference of 12-hour AUCHypercholesterolemiaHyperlipidemia

Phase 2

AEGR-733 and Atorvastatin 20 mg vs. Monotherapy in Moderate Hypercholesterolemia
CompletedNCT00474240
Aegerion Pharmaceuticals, Inc.Hypercholesterolemia
Start: 2007-04-30End: 2008-10-31Updated: 2018-03-20
Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis
RecruitingNCT06764966
CAMC Health SystemCirrhosis, Decompensated Cirrhosis and Ascites, Decompensated Cirrhosis of Liver +1
Start: 2025-09-09End: 2027-03-01Target: 50Updated: 2026-02-25
ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)
RecruitingNCT07303699
Obafemi Awolowo University Teaching HospitalPulmonary Tuberculosis (TB)
Start: 2026-01-03End: 2028-03-30Target: 80Updated: 2026-01-23

Phase 3

A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)
CompletedNCT00535405
Organon and CoHypercholesterolemia
Start: 2007-11-30End: 2009-03-31Updated: 2024-05-16
Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED)
CompletedNCT00782184
Organon and CoHypercholesterolemia
Start: 2008-11-30End: 2010-09-30Updated: 2024-05-16
An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)
CompletedNCT03867110
Organon and CoHypercholesterolemia
Start: 2000-03-06End: 2001-07-27Updated: 2024-05-10

Phase 4

Intensive Statin Therapy Effect on Post-Operative Atrial Fibrillation (POAF)
NCT02029534
Creighton UniversityCardiothoracic Surgery, Post-operative Atrial Fibrillation
Start: 2013-08-31End: 2017-06-30Target: 200Updated: 2016-06-16
Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population
RecruitingNCT06789432
Dr. Md. Alimur RezaHyperlipidemia (E.G., Hypercholesterolemia)
Start: 2025-02-01End: 2025-12-31Target: 500Updated: 2025-07-29

Unknown Phase

Pharmacokinetic of Everolimus and Atorvastatin Co-administration
CompletedNCT01780948
Chulalongkorn UniversityDifference of 12-hour AUC
Start: 2012-09-30End: 2013-01-31Updated: 2013-02-08
Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia
CompletedNCT02942602
Yonsei UniversityHyperlipidemia
Start: 2014-04-03End: 2016-05-23Updated: 2018-07-18

Related Papers

Effect of two lipid-lowering strategies on high-density lipoprotein function and some HDL-related proteins: a randomized clinical trial
Lipids in Health and Disease2017-02-2810 citations
Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study.
2012-01-319 citations